Ads

 

Ads

 

Ads

 

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026

World Top 100 Pharmaceutical Companies List by Market Cap as of August 2026, World Biggest 100 Pharmaceutical Companies by Market Cap, World Largest 100 Pharmaceutical Companies in the World by market cap as of August 2026.

Metatag Title
World Top Pharmaceutical Companies in 2026
Metatag Abstract
World Top Pharmaceutical Companies by Market Cap in 2026, World Largest Pharmaceutical Companies by Market Cap in 2026.
  1. Momenta Pharmaceuticals

    World Rank (Aug-2026)
    5,297
    World Rank (Jan-05-2024)
    5,297
    World Rank (Jul-30-2023)
    5,297
    World Rank (Dec-25-2022)
    5,297
    World Rank (Jan-07-2022)
    5,297
    Annual Revenue in USD
    24 Million USD
    Annual Operating Income in USD
    -298 Million USD
    Annual Net Income in USD
    -290 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    Company Profile

    Momenta Pharmaceuticals is a Biotechnology company. The headquarters is in USA.

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD.

    Facts About Company

    Johnson & Johnson acquired Momenta Pharmaceuticals as on Oct-2020 for 6.5 Billion USD

  2. Regencell Bioscience Holdings Ltd

    World Rank (Aug-2026)
    5,355
    Market Cap (Aug-2026)
    2.695 Billion USD
    World Rank (Jan-05-2024)
    19,846
    Market Cap (Jan-05-2024)
    0.137 Billion USD
    World Rank (Jul-30-2023)
    16,994
    Market Cap (Jul-30-2023)
    0.243 Billion USD
    World Rank (Dec-25-2022)
    14,236
    Market Cap (Dec-25-2022)
    0.380 Billion USD
    World Rank (Jan-07-2022)
    14,583
    Market Cap (Jan-07-2022)
    0.42 Billion USD
    Headquarters Country
  3. Piramal Enterprises

    World Rank (Aug-2026)
    5,419
    Market Cap (Aug-2026)
    2.647 Billion USD
    World Rank (Jan-05-2024)
    4,900
    Market Cap (Jan-05-2024)
    2.546 Billion USD
    World Rank (Jul-30-2023)
    4,241
    Market Cap (Jul-30-2023)
    3.112 Billion USD
    World Rank (Dec-25-2022)
    4,900
    Market Cap (Dec-25-2022)
    2.336 Billion USD
    World Rank (Jan-07-2022)
    2,307
    Market Cap (Jan-07-2022)
    7.79 Billion USD
    Annual Revenue in USD
    1,731 Million USD
    Annual Net Income in USD
    241 Million USD
    Annual Results for Period Ending
    Mar-2022 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Piramal Group is a global business conglomerate with diverse interests in Pharma, Financial Services, Information Management, Real Estate and Glass Packaging. The Group has offices in over 30 countries and a global brand presence in more than 100 markets. Headquarters is in Mumbai of India.

  4. Curaleaf Holdings

    World Rank (Aug-2026)
    5,427
    Market Cap (Aug-2026)
    2.640 Billion USD
    World Rank (Jan-05-2024)
    4,281
    Market Cap (Jan-05-2024)
    3.093 Billion USD
    World Rank (Jul-30-2023)
    4,927
    Market Cap (Jul-30-2023)
    2.505 Billion USD
    World Rank (Dec-25-2022)
    4,010
    Market Cap (Dec-25-2022)
    3.075 Billion USD
    World Rank (Jan-07-2022)
    2,855
    Market Cap (Jan-07-2022)
    5.93 Billion USD
    Annual Revenue in USD
    1,268 Million USD
    Annual Operating Income in USD
    25 Million USD
    Annual Net Income in USD
    -231 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Curaleaf Holdings is a Cannabis company. Curaleaf has a presence in 23 states, owns and operates 101 dispensaries, 23 cultivation sites, and 30 processing sites with a focus on highly populated, limited license states, including Arizona, Florida, Illinois, Massachusetts, New Jersey, New York, and Pennsylvania. The headquarters is in USA.

  5. Portola Pharmaceuticals

    World Rank (Aug-2026)
    5,432
    World Rank (Jan-05-2024)
    5,432
    World Rank (Jul-30-2023)
    5,432
    World Rank (Dec-25-2022)
    5,432
    World Rank (Jan-07-2022)
    5,432
    Annual Revenue in USD
    117 Million USD
    Annual Operating Income in USD
    -271 Million USD
    Annual Net Income in USD
    -291 Million USD
    Annual Results for Period Ending
    For year ending December-2019
    Headquarters Country
    Company Profile

    Portola Pharmaceuticals is a Biotechnology company. It is having more than 380 employees and has offices around the globe and serves patients in more than 50 countries. The company has developed and commercializes two approved complement inhibitors to treat patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome (aHUS) as well as the first and only approved complement inhibitor to treat anti-acetylcholine receptor (AchR) antibody-positive generalized myasthenia gravis (gMG) and neuromyelitis optica spectrum disorder.

  6. Haw Par Corporation

    World Rank (Aug-2026)
    5,449
    Market Cap (Aug-2026)
    2.624 Billion USD
    World Rank (Jan-05-2024)
    6,452
    Market Cap (Jan-05-2024)
    1.626 Billion USD
    World Rank (Jul-30-2023)
    6,583
    Market Cap (Jul-30-2023)
    1.605 Billion USD
    World Rank (Dec-25-2022)
    6,400
    Market Cap (Dec-25-2022)
    1.558 Billion USD
    World Rank (Jan-07-2022)
    6,517
    Market Cap (Jan-07-2022)
    1.89 Billion USD
    Annual Revenue in USD
    103 Million USD
    Annual Net Income in USD
    81 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Stock Category
    Company Profile

    Haw Par Group is an enterprise with a strong consumer healthcare business that promotes healthy lifestyles through its healthcare products. Headquarters is in Singapore.

  7. Aphria

    World Rank (Aug-2026)
    5,459
    World Rank (Jan-05-2024)
    5,459
    World Rank (Jul-30-2023)
    5,459
    World Rank (Dec-25-2022)
    5,459
    World Rank (Jan-07-2022)
    5,459
    Headquarters Country
    Company Profile
    Aphria is a Canadian Cannabis company. It has a market capitalization of $1.2 billion as of January 2020. The headquarters is in Canada.
  8. Ultragenyx Pharmaceutical

    World Rank (Aug-2026)
    5,466
    Market Cap (Aug-2026)
    2.612 Billion USD
    World Rank (Jan-05-2024)
    3,549
    Market Cap (Jan-05-2024)
    3.941 Billion USD
    World Rank (Jul-30-2023)
    4,303
    Market Cap (Jul-30-2023)
    3.053 Billion USD
    World Rank (Dec-25-2022)
    4,035
    Market Cap (Dec-25-2022)
    3.051 Billion USD
    World Rank (Jan-07-2022)
    3,267
    Market Cap (Jan-07-2022)
    5.03 Billion USD
    Annual Revenue in USD
    673 Million USD
    Annual Operating Income in USD
    -535 Million USD
    Annual Net Income in USD
    -575 Million USD
    Annual Results for Period Ending
    For year ending December-2025
    Headquarters Country
    Company Profile

    Ultragenyx Pharmaceutical is a Clinical Stage Biopharmaceutical company. It committed to bringing to patients novel products for the treatment of rare and ultra rare diseases with a focus on serious debilitating genetic diseases. The company portfolio of approved therapies and product candidates aimed at addressing diseases with high unmet medical need and clear biology for which there are no approved therapies. The headquarters is in USA.

  9. Sawai Pharmaceutical

    World Rank (Aug-2026)
    5,467
    World Rank (Jan-05-2024)
    5,467
    World Rank (Jul-30-2023)
    5,467
    World Rank (Dec-25-2022)
    5,467
    World Rank (Jan-07-2022)
    5,467
    Annual Revenue in USD
    1,678 Million USD
    Annual Net Income in USD
    177 Million USD
    Annual Results for Period Ending
    Mar-2020 ending year
    Headquarters Country
  10. Kobayashi Pharmaceutical

    World Rank (Aug-2026)
    5,530
    Market Cap (Aug-2026)
    2.559 Billion USD
    World Rank (Jan-05-2024)
    3,969
    Market Cap (Jan-05-2024)
    3.401 Billion USD
    World Rank (Jul-30-2023)
    3,432
    Market Cap (Jul-30-2023)
    4.195 Billion USD
    World Rank (Dec-25-2022)
    2,775
    Market Cap (Dec-25-2022)
    4.901 Billion USD
    World Rank (Jan-07-2022)
    2,826
    Market Cap (Jan-07-2022)
    6.01 Billion USD
    Annual Revenue in USD
    1,229 Million USD
    Annual Net Income in USD
    156 Million USD
    Annual Results for Period Ending
    Dec-2021 ending year
    Headquarters Country
    Company Profile
    Kobayashi Pharmaceutical is a Manufacturing and sales of OTC pharmaceuticals, guasi drugs, deodorizing air fresheners and sanitary products company. It Common Stock is 3,450 million yen and employees is 4849. The headquarters is in Japan.

Share

Ads